US Patent Issued to Regents of the University of Minnesota on April 15 for "Affibody proteins specific for B7-H3 (CD276)" (California, Minnesota, Texas Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,759, issued on April 15, was assigned to Regents of the University of Minnesota (Minneapolis).

"Affibody proteins specific for B7-H3 (CD276)" was invented by Lotfi Abou-Elkacem (Houston), Juergen Karl Willmann (Stanford, Calif.), Benjamin J. Hackel (Edina, Minn.), Lawrence Arthur Stern (Monrovia, Calif.), Patrick Samuel Lown (Minneapolis), Amelie Margarete Marianne Lutz (Stanford, Calif.) and Rakesh Kumar Bam (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Affibody polypeptides that specifically bind to B7-H3 are provided. Exemplary anti-B7-H3 affibodies are provided. The affibody polypeptides specifically recognize and bind to B7-...